• About
  • Masthead
  • License Content
  • Advertise
  • Submit Press Release
  • RSS/Email List
  • Write for us
  • Contact us
2 Minute Medicine
No Result
View All Result

No products in the cart.

SUBSCRIBE
  • Specialties
    • Cardiology
    • Chronic Disease
    • Dermatology
    • Emergency
    • Endocrinology
    • Gastroenterology
    • Imaging and Intervention
    • Infectious Disease
    • Nephrology
    • Neurology
    • Obstetrics
    • Oncology
    • Ophthalmology
    • Pediatrics
    • Preclinical
    • Psychiatry
    • Public Health
    • Pulmonology
    • Rheumatology
    • Surgery
  • Wellness
  • Classics™
    • 2MM+ Online Access
    • Paperback and Ebook
  • Rewinds
  • Visual
  • Partners
    • License Content
    • Submit Press Release
    • Advertise with Us
  • AccountLog-in/out
    • Subscribe
    • Sign-in
    • My account
2 Minute Medicine
  • Specialties
    • Cardiology
    • Chronic Disease
    • Dermatology
    • Emergency
    • Endocrinology
    • Gastroenterology
    • Imaging and Intervention
    • Infectious Disease
    • Nephrology
    • Neurology
    • Obstetrics
    • Oncology
    • Ophthalmology
    • Pediatrics
    • Preclinical
    • Psychiatry
    • Public Health
    • Pulmonology
    • Rheumatology
    • Surgery
  • Wellness
  • Classics™
    • 2MM+ Online Access
    • Paperback and Ebook
  • Rewinds
  • Visual
  • Partners
    • License Content
    • Submit Press Release
    • Advertise with Us
  • AccountLog-in/out
    • Subscribe
    • Sign-in
    • My account
SUBSCRIBE
2 Minute Medicine
Subscribe
Home All Specialties Infectious Disease

Lower than expected seropositivity among vaccinated university students during N. meningitidis outbreak

byDavid ArsaniousandShaidah Deghan, MSc. MD
July 21, 2016
in Infectious Disease, Public Health
Reading Time: 2 mins read
0
Share on FacebookShare on Twitter

1. In response to a meningococcal B outbreak at a US university in 2013 and 2014, the FDA approved the use of a recombinant meningoccal B vaccine (4CMenB) before licensure.

2. Among a sample of students who revived two doses of the 4CMenB vaccine, nearly one-third were found to be seronegative to the outbreak strain.

Evidence Rating Level: 2 (Good)       

Study Rundown: Although the incidence of meningococcal disease in the United States has been declining, due in part to the vaccination of adolescents with meningococcal A, C, W, and Y vaccines, protection against N. mengitidis serogroup B has remained challenging as a result of antigenic similarities between the meningococcal B polysaccharide and human glycoproteins. In the face of a meningococcal B outbreak on a university campus in 2013-2014, in which nine cases of disease and one death were discovered, the US FDA approved the administration of the recombinant meningococcal B vaccine 4CMenB to select students prior to its licensure.

Titers for human serum bactericidal antibodies (hBSA) against the outbreak strain were quantified to assess seroprevalence among individuals who were eligible to receive the vaccine. Among the students who recommended 4CMenB vaccine schedule of two doses 10 weeks apart, approximately two-thirds were found to be seropositive for the outbreak strain. This study draws strength from the authors’ choice to compare seropositivity for the outbreak strain to a vaccine reference stain, in which the discrepancy between the two demonstrated that immunity could be greatly overestimated unless it is the specific outbreak strain that is used to predict immunity. A notable limitation of the study, however, is the small number of students who chose to forgo vaccination.

Click to read the study, published today in NEJM

Relevant Reading: Multivalent meningococcal serogroup B vaccines: challenges in predicting protection and measuring effectiveness.

RELATED REPORTS

Effectiveness of second dose of COVID-19 vaccines over a 6 month period

BNT162b2 booster dose associated with reduced risk of SARS-CoV-2 infection and mortality among older adults in long-term care facilities

RSVpreF vaccine prevents symptomatic respiratory syncytial virus infection

In-Depth [cross-sectional study]: The 4CMenB vaccine was offered to nearly 6000 students: graduate students living on campus and all undergraduates enrolled at the time of the outbreak. Within six months, 95% of students had received at least one dose, and 89% had completed the recommended two-dose series. All students eligible for the vaccination campaigns were invited to participate in the seroprevalence study. Seropositivity was defined as a hBSA titer ≥4. Of the 499 tested students who received two doses of 4CMenB, 330 (66.1%; 95%CI 61.8-70.3) were seropositive. Of the 17 tested students who received one dose of 4CMenB, 10 (58.8%; 95%CI 32.9-81.6) were seropositive. Of the 19 unvaccinated students who were tested, 4 (21.1%; 95%CI 6.1-45.6) were seropositive. There was no significant between-group difference in seropositivity in those receiving one or two doses of 4CMenB (p = 0.53). Significant between-group differences for seropositivity were found in two doses vs no dose (p < 0.001) and one dose vs no dose (p = 0.03).

Image: PD

©2016 2 Minute Medicine, Inc. All rights reserved. No works may be reproduced without expressed written consent from 2 Minute Medicine, Inc. Inquire about licensing here. No article should be construed as medical advice and is not intended as such by the authors or by 2 Minute Medicine, Inc.

Tags: meningitisvaccine
Previous Post

Extending adjuvant letrozole treatment may reduce breast cancer recurrence: The MA.17R trial

Next Post

All glucose-lowering medications effective, but some offer lower hypoglycemia risks

RelatedReports

Medical vaccine exemptions increase after elimination of nonmedical exemptions
Infectious Disease

Effectiveness of second dose of COVID-19 vaccines over a 6 month period

July 26, 2022
Compliance-linked incentives increase infant immunizations rates in rural India
Chronic Disease

BNT162b2 booster dose associated with reduced risk of SARS-CoV-2 infection and mortality among older adults in long-term care facilities

July 8, 2022
RSV positivity associated with reduced serious bacterial infection risk [Classics Series]
Infectious Disease

RSVpreF vaccine prevents symptomatic respiratory syncytial virus infection

June 24, 2022
Atrial fibrillation-specific management increases days alive and out of hospital
Cardiology

Risk of myocarditis or pericarditis after COVID-19 mRNA vaccination is highest among younger males

June 22, 2022
Next Post
Pediatric DKA associated with recent acute care visits

All glucose-lowering medications effective, but some offer lower hypoglycemia risks

Longer duration of elastic compression therapy may help prevent post-thrombotic syndrome

Longer duration of elastic compression therapy may help prevent post-thrombotic syndrome

Participation in sports and exercise linked to lower opioid use

Participation in sports and exercise linked to lower opioid use

License Our Award-Winning Physician-Written Medical News and Visual Abstracts

2 Minute Medicine is the leading authoritative medical news licensing service, and the only with reports written by practicing doctors.

LICENSE CONTENT

2MM+ Premium Access

No ads & unlimited access to all current reports, over 9000 searchable archived reports, visual abstracts, Weekly Rewinds, and the online edition of The Classics Series™ textbook.

Subscription Options
2 Minute Medicine

2 Minute Medicine® is an award winning, physician-run, expert medical media company. Our content is curated, written and edited by practicing health professionals who have clinical and scientific expertise in their field of reporting. Our editorial management team is comprised of highly-trained MD physicians. Join numerous brands, companies, and hospitals who trust our licensed content.

Recent Reports

  • Subthreshold micropulse laser is equivalent to standard laser for treating diabetic macular edema
  • Gadolinium-containing contrast associated with nephrogenic fibrosing dermopathy and systemic fibrosis [Classics Series]
  • Study supports continued use of amoxicillin as first-line therapy for pediatric ear infections
License Content
Terms of Use | Disclaimer
Cookie Policy
Privacy Statement (EU)
Disclaimer

© 2021 2 Minute Medicine, Inc. - Physician-written medical news.

  • Specialties
    • Cardiology
    • Chronic Disease
    • Dermatology
    • Emergency
    • Endocrinology
    • Gastroenterology
    • Imaging and Intervention
    • Infectious Disease
    • Nephrology
    • Neurology
    • Obstetrics
    • Oncology
    • Ophthalmology
    • Pediatrics
    • Preclinical
    • Psychiatry
    • Public Health
    • Pulmonology
    • Rheumatology
    • Surgery
  • Wellness
  • Classics™
    • 2MM+ Online Access
    • Paperback and Ebook
  • Rewinds
  • Visual
  • Partners
    • License Content
    • Submit Press Release
    • Advertise with Us
  • Account
    • Subscribe
    • Sign-in
    • My account

© 2021 2 Minute Medicine, Inc. - Physician-written medical news.